Referencias
Artículos principales
Nunes MCP, Beaton A, Acquatella H, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018 Sep 18;138(12):e169-209.Texto completo Resumen
Dias JC, Ramos AN Jr, Gontijo ED, et al. 2 nd Brazilian Consensus on Chagas disease, 2015. Rev Soc Bras Med Trop. 2016 Dec;49Suppl 1(Suppl 1):3-60.Texto completo Resumen
Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007 Nov 14;298(18):2171-81.Texto completo Resumen
Meymandi S, Hernandez S, Park S, et al. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018 Jun 26;10(3):373-88.Texto completo Resumen
Pan American Health Organization. Guide to the diagnosis and treatment of chagas disease. Jun 2019 [internet publication].Texto completo
World Health Organization. Chagas disease (American trypanosomiasis): treatment. 2018 [internet publication].Texto completo
Artículos de referencia
1. Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018 Jan 6;391(10115):82-94. Resumen
2. Nunes MCP, Beaton A, Acquatella H, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018 Sep 18;138(12):e169-209.Texto completo Resumen
3. Gómez-Ochoa SA, Rojas LZ, Echeverría LE, et al. Global, regional, and national trends of Chagas disease from 1990 to 2019: comprehensive analysis of the Global Burden of Disease study. Glob Heart. 2022;17(1):59.Texto completo Resumen
4. Dias JC, Ramos AN Jr, Gontijo ED, et al. 2 nd Brazilian Consensus on Chagas disease, 2015. Rev Soc Bras Med Trop. 2016 Dec;49Suppl 1(Suppl 1):3-60.Texto completo Resumen
5. Pierrotti LC, Ibrahim KY. Chagas disease: coming to a transplanted patient near you. Springer, Cham. 2020 Mar 09;1-47.
6. Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, et al. Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions". PLoS Negl Trop Dis. 2021 Sep 30;15(9):e0009809.Texto completo Resumen
7. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Chagas disease. 2023 [internet publication].Texto completo
8. Shikanai-Yasuda MA, de Almeida EA, López MC, et al. Chagas disease: a parasitic infection in an immunosuppressed host. Springer, Cham. 2020 Jul 21;213-34.
9. Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clin Infect Dis. 2012 Mar;54(6):845-52.Texto completo Resumen
10. Pereira KS, Schmidt FL, Barbosa RL, et al. Transmission of Chagas disease (American trypanosomiasis) by food. Adv Food Nutr Res. 2010;59:63-85. Resumen
11. Bennett C, Straily A, Haselow D, et al. Chagas disease surveillance activities - seven states, 2017. MMWR Morb Mortal Wkly Rep. 2018 Jul 6;67(26):738-41.Texto completo Resumen
12. Coura JR, Dias JC. Epidemiology, control and surveillance of Chagas disease - 100 years after its discovery. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:31-40.Texto completo Resumen
13. Brazilian Ministry of Health. Brazilian consensus on Chagas disease [in Portuguese]. Rev Soc Bras Med Trop. 2005;38(suppl 3):7-29. Resumen
14. Andrade JP, Marin Neto JA, Paola AA, et al. I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011 Jun;96(6):434-42.Texto completo Resumen
15. Pinazo MJ, Miranda B, Rodríguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando). 2011 Jul;25(3):91-101. Resumen
16. Sartori AM, Sotto MN, Braz LM, et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):631-2. Resumen
17. Ramos AN Jr. Inclusion of Chagas' disease reactivation as a condition for AIDS case definition to epidemiological surveillance in Brazil [in Portuguese]. Rev Soc Bras Med Trop. 2004 Mar-Apr;37(2):192-3.Texto completo Resumen
18. Sartori AM, Neto JE, Nunes EV, et al. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis. 2002 Sep 15;186(6):872-5.Texto completo Resumen
19. Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients - a review. Mem Inst Oswaldo Cruz. 2002 Jun;97(4):443-57.Texto completo Resumen
20. Ferreira MS. Chagas disease and immunosuppression. Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:325-7.Texto completo
21. Gray EB, La Hoz RM, Green JS, et al. Reactivation of Chagas disease among heart transplant recipients in the United States, 2012-2016. Transpl Infect Dis. 2018 Dec;20(6):e12996. Resumen
22. Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:101-7.Texto completo Resumen
23. Pinto AY, Ferreira AG Jr, Valente Vda C, et al. Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Rev Panam Salud Publica. 2009 Jan;25(1):77-83. Resumen
24. Pan American Health Organization. Guía para vigilancia, prevención, controle y manejo clínico da doença de Chagas aguda transmitida por alimentos [in Portuguese]. Rio de Janeiro, Brazil: PANAFTOSA-VP/OPAS/OMS: PAHO/HSD/CD/539.09; 2009:92.Texto completo
25. Alarcón de Noya B, Díaz-Bello Z, Colmenares C, et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis. 2010 May 1;201(9):1308-15.Texto completo Resumen
26. Dias JC, Coura JR. Clinica e terapeutica da doença de Chagas. Rio de Janeiro, Brazil: FIOCRUZ; 1997:486.
27. World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43.Texto completo Resumen
28. TDR. Report of the scientific working group on Chagas disease, 17-20 April 2005 [in Spanish]. Buenos Aires, Argentina; 2007.Texto completo
29. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009;104(suppl 1):17-30.Texto completo Resumen
30. Bruneto EG, Fernandes-Silva MM, Toledo-Cornell C, et al. Case-fatality from orally-transmitted acute chagas disease: a systematic review and meta-analysis. Clin Infect Dis. 2021 Mar 15;72(6):1084-92.Texto completo Resumen
31. Pinto Dias JC. Human Chagas disease and migration in the context of globalization: some particular aspects. J Trop Med. 2013;2013:789758.Texto completo Resumen
32. Coura JR, Viñas PA, Junqueira AC. Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries. Mem Inst Oswaldo Cruz. 2014 Nov;109(7):856-62.Texto completo Resumen
33. Laynez-Roldán P, Losada-Galván I, Posada E, et al. Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement. PLoS Negl Trop Dis. 2023 Jul;17(7):e0011330.Texto completo Resumen
34. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007 Nov 14;298(18):2171-81.Texto completo Resumen
35. Kirchhoff LV. American trypanosomiasis (Chagas' disease) - a tropical disease now in the United States. N Engl J Med. 1993 Aug 26;329(9):639-44. Resumen
36. Busselman RE, Hamer SA. Chagas disease ecology in the United States: recent advances in understanding Trypanosoma cruzi transmission among triatomines, wildlife, and domestic animals and a quantitative synthesis of vector-host interactions. Annu Rev Anim Biosci. 2022 Feb 15;10:325-48.Texto completo Resumen
37. Strasen J, Williams T, Ertl G, et al. Epidemiology of Chagas disease in Europe: many calculations, little knowledge. Clin Res Cardiol. 2014 Jan;103(1):1-10. Resumen
38. Klotz SA, Dorn PL, Klotz JH, et al. Feeding behavior of triatomines from the southwestern United States: an update on potential risk for transmission of Chagas disease. Acta Trop. 2009 Aug;111(2):114-8. Resumen
39. Hall CA, Polizzi C, Yabsley MJ, et al. Trypanosoma cruzi prevalence and epidemiologic trends in lemurs on St. Catherines Island, Georgia. J Parasitol. 2007 Feb;93(1):93-6. Resumen
40. Coura JR, Borges-Pereira J. Chagas disease. What is known and what should be improved: a systemic review. Rev Soc Bras Med Trop. 2012 Jun;45(3):286-96.Texto completo Resumen
41. Buekens P, Almendares O, Carlier Y, et al. Mother-to-child transmission of Chagas' disease in North America: why don't we do more? Matern Child Health J. 2008 May;12(3):283-6. Resumen
42. Coura JR. The main sceneries of Chagas disease transmission: the vectors, blood and oral transmissions - a comprehensive review. Mem Inst Oswaldo Cruz. 2015 May;110(3):277-82.Texto completo Resumen
43. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001 Sep;1(2):92-100. Resumen
44. Roque AL, Xavier SC, da Rocha MG, et al. Trypanosoma cruzi transmission cycle among wild and domestic mammals in three areas of orally transmitted Chagas disease outbreaks. Am J Trop Med Hyg. 2008 Nov;79(5):742-9. Resumen
45. Roque AL, Xavier SC, Gerhardt M, et al. Trypanosoma cruzi among wild and domestic mammals in different areas of the Abaetetuba municipality (Pará State, Brazil), an endemic Chagas disease transmission area. Vet Parasitol. 2013 Mar 31;193(1-3):71-7.Texto completo Resumen
46. Roux E, de Fátima Venâncio A, Girres JF, et al. Spatial patterns and eco-epidemiological systems--part II: characterising spatial patterns of the occurrence of the insect vectors of Chagas disease based on remote sensing and field data. Geospat Health. 2011 Nov;6(1):53-64. Resumen
47. Roux E, de Fátima Venâncio A, Girres JF, et al. Spatial patterns and eco-epidemiological systems--part I: multi-scale spatial modelling of the occurrence of Chagas disease insect vectors. Geospat Health. 2011 Nov;6(1):41-51. Resumen
48. Costa J, Lorenzo M. Biology, diversity and strategies for the monitoring and control of triatomines - Chagas disease vectors. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:46-51.Texto completo Resumen
49. Justi SA, Russo CA, Mallet JR, et al. Molecular phylogeny of Triatomini (Hemiptera: Reduviidae: Triatominae). Parasit Vectors. 2014 Mar 31;7:149.Texto completo Resumen
50. Justi SA, Galvão C. The Evolutionary Origin of Diversity in Chagas Disease Vectors. Trends Parasitol. 2017 Jan;33(1):42-52.Texto completo Resumen
51. Ferrari A, Janisch Alvares D, Buratto PM, et al. Distribution patterns of triatominae (hemiptera: reduviidae) in the Americas: an analysis based on networks and endemicity. Cladistics. 2022 Oct;38(5):563-81. Resumen
52. Herrera CP, Licon MH, Nation CS, et al. Genotype diversity of Trypanosoma cruzi in small rodents and Triatoma sanguisuga from a rural area in New Orleans, Louisiana. Parasit Vectors. 2015 Feb 24;8:123.Texto completo Resumen
53. Waleckx E, Suarez J, Richards B, et al. Triatoma sanguisuga blood meals and potential for Chagas disease, Louisiana, USA. Emerg Infect Dis. 2014 Dec;20(12):2141-3.Texto completo Resumen
54. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009 Sep 1;49(5):e52-4.Texto completo Resumen
55. Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev. 2001 Oct;14(4):659-88.Texto completo Resumen
56. Messenger LA, Bern C. Congenital Chagas disease: current diagnostics, limitations and future perspectives. Curr Opin Infect Dis. 2018 Oct;31(5):415-21. Resumen
57. Luquetti AO, Tavares SBN, Siriano LR, et al. Congenital transmission of Trypanosoma cruzi in central Brazil: a study of 1,211 individuals born to infected mothers. Mem Inst Oswaldo Cruz. 2015 May;110(3):369-76.Texto completo Resumen
58. Howard EJ, Xiong X, Carlier Y, et al. Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis. BJOG. 2014 Jan;121(1):22-33.Texto completo Resumen
59. Bern C, Verastegui M, Gilman RH, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis. 2009 Dec 1;49(11):1667-74.Texto completo Resumen
60. Abras A, Ballart C, Fernández-Arévalo A, et al. Worldwide control and management of chagas disease in a new era of globalization: a close look at congenital trypanosoma cruzi infection. Clin Microbiol Rev. 2022 Apr 20;35(2):e0015221.Texto completo Resumen
61. Klein MD, Proaño A, Noazin S, et al. Risk factors for vertical transmission of Chagas disease: a systematic review and meta-analysis. Int J Infect Dis. 2021 Apr;105:357-73.Texto completo Resumen
62. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:152-8.Texto completo Resumen
63. Marin-Neto JA, Cunha-Neto E, Maciel BC, et al. Pathogenesis of chronic Chagas heart disease. Circulation. 2007 Mar 6;115(9):1109-23.Texto completo Resumen
64. Esper L, Talvani A, Pimentel P, et al. Molecular mechanisms of myocarditis caused by Trypanosoma cruzi. Curr Opin Infect Dis. 2015 Jun;28(3):246-52. Resumen
65. Cunha-Neto E, Chevillard C. Chagas disease cardiomyopathy: immunopathology and genetics. Mediators Inflamm. 2014;2014:683230.Texto completo Resumen
66. da Rocha JR, Ribeiro U, Cecconello I, et al. Gastric secretory and hormonal patterns in end-stage Chagasic achalasia. Dis Esophagus. 2009;22(7):606-10. Resumen
67. Dutra WO, Gollob KJ. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis. 2008 Jun;21(3):287-92. Resumen
68. Meneghelli UG. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res. 1985;18(3):255-64. Resumen
69. Jabari S, de Oliveira EC, Brehmer A, et al. Chagasic megacolon: enteric neurons and related structures. Histochem Cell Biol. 2014 Sep;142(3):235-44.Texto completo Resumen
70. García Orozco VH, Villalvazo Navarro JE, Aguirre CS, et al. Chagas disease - from cellular and molecular aspects of Trypanosoma cruzi-host interactions to the clinical intervention. In: Menna-Barreto R, ed. Digestive disorders in Chagas disease: megaesophagus and chagasic megacolon. London: IntechOpen; 2022:183.Texto completo
71. Jiménez P, Jaimes J, Poveda C, et al. A systematic review of the Trypanosoma cruzi genetic heterogeneity, host immune response and genetic factors as plausible drivers of chronic chagasic cardiomyopathy. Parasitology. 2019 Mar;146(3):269-83. Resumen
72. Hasslocher-Moreno AM, Xavier SS, Saraiva RM, et al. Indeterminate form of Chagas disease: historical, conceptual, clinical, and prognostic aspects. Rev Soc Bras Med Trop. 2021;54:e02542021.Texto completo Resumen
73. Klotz SA, Dorn PL, Mosbacher M, et al. Kissing bugs in the United States: risk for vector-borne disease in humans. Environ Health Insights. 2014 Dec 10;8(Suppl 2):49-59.Texto completo Resumen
74. Dias JC. Chagas disease control in Brazil: which strategy after the attack phase? Ann Soc Belg Med Trop. 1991;71(suppl 1):75-86. Resumen
75. Briceño-León R. Chagas disease in the Americas: an ecohealth perspective. Cad Saude Publica. 2009;25(suppl 1):S71-82. Resumen
76. Gorla DE, Porcasi X, Hrellac H, et al. Spatial stratification of house infestation by Triatoma infestans in La Rioja, Argentina. Am J Trop Med Hyg. 2009 Mar;80(3):405-9. Resumen
77. Briceño-León R, Mendez Galván J. The social determinants of Chagas disease and the transformations of Latin America. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:109-12.Texto completo Resumen
78. Araujo CA, Waniek PJ, Jansen AM. An overview of Chagas disease and the role of triatomines on its distribution in Brazil. Vector Borne Zoonotic Dis. 2009 Jun;9(3):227-34. Resumen
79. Hotez PJ. Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis. 2008 Jun 25;2(6):e256.Texto completo Resumen
80. Ventura-Garcia L, Roura M, Pell C, et al. Socio-cultural aspects of Chagas disease: a systematic review of qualitative research. PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2410.Texto completo Resumen
81. Castro E. Chagas' disease: lessons from routine donation testing. Transfus Med. 2009 Feb;19(1):16-23.Texto completo Resumen
82. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:75-85.Texto completo Resumen
83. Agapova M, Busch MP, Custer B. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion. 2010 Oct;50(10):2220-32. Resumen
84. Diaz JH. Recognizing and reducing the risks of Chagas disease (American trypanosomiasis) in travelers. J Travel Med. 2008 May-Jun;15(3):184-95.Texto completo Resumen
85. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, et al. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion. 2006 Feb;46(2):298-304. Resumen
86. Wendel S. Transfusion-transmitted Chagas' disease. Curr Opin Hematol. 1998 Nov;5(6):406-11. Resumen
87. Sabino EC, Salles NA, Sarr M, et al; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil. Transfusion. 2010 Dec;50(12):2628-37. Resumen
88. Altclas JD, Barcan L, Nagel C, et al. Organ transplantation and Chagas disease. JAMA. 2008 Mar 12;299(10):1134; author reply 1134-5. Resumen
89. Ferraz AS, Figueiredo JF. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo. 1993 Sep-Oct;35(5):461-3. Resumen
90. Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis. 2009 Jun 1;48(11):1534-40. Resumen
91. Barcán L, Lunaó C, Clara L, et al. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease. Liver Transpl. 2005 Sep;11(9):1112-6.Texto completo Resumen
92. Souza FF, Castro-E-Silva O, Marin Neto JA, et al. Acute Chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc. 2008 Apr;40(3):875-8. Resumen
93. Kransdorf EP, Zakowski PC, Kobashigawa JA. Chagas disease in solid organ and heart transplantation. Curr Opin Infect Dis. 2014 Oct;27(5):418-24. Resumen
94. Wallace JA, Miller L, Beavis A, et al. Chagas disease: a proposal for testing policy for solid-organ transplant in the United States. Prog Transplant. 2013 Sep;23(3):272-7. Resumen
95. Villalba R, Fornes G, Alvarez MA, et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis. 1992 Feb;14(2):594-5. Resumen
96. Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005 Jul;36(2):123-9.Texto completo Resumen
97. Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transpl Infect Dis. 1999 Jun;1(2):135-7. Resumen
98. Altclas J, Jaimovich G, Milovic V, et al. Chagas' disease after bone marrow transplantation. Bone Marrow Transplant. 1996 Aug;18(2):447-8. Resumen
99. Vazquez-Prokopec GM, Ceballos LA, Cecere MC, et al. Seasonal variations of microclimatic conditions in domestic and peridomestic habitats of Triatoma infestans in rural northwest Argentina. Acta Trop. 2002 Dec;84(3):229-38. Resumen
100. Medone P, Ceccarelli S, Parham PE, et al. The impact of climate change on the geographical distribution of two vectors of Chagas disease: implications for the force of infection. Philos Trans R Soc Lond B Biol Sci. 2015 Apr 5;370(1665). pii: 20130560. Resumen
101. Garza M, Feria Arroyo TP, Casillas EA, et al. Projected future distributions of vectors of Trypanosoma cruzi in North America under climate change scenarios. PLoS Negl Trop Dis. 2014 May 15;8(5):e2818.Texto completo Resumen
102. Abad-Franch F, Monteiro FA. Biogeography and evolution of Amazonian triatomines (Heteroptera: Reduviidae): implications for Chagas disease surveillance in humid forest ecoregions. Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:57-70.Texto completo Resumen
103. Walsh JF, Molyneux DH, Birley MH. Deforestation: effects on vector-borne disease. Parasitology. 1993;106 Suppl:S55-75. Resumen
104. Hofflin JM, Sadler RH, Araujo FG, et al. Laboratory-acquired Chagas disease. Trans R Soc Trop Med Hyg. 1987;81(3):437-40. Resumen
105. Bern C, Montgomery SP. Recognizing and reducing the risks of Chagas disease in travelers. J Travel Med. 2008 Sep-Oct;15(5):385; author reply 386.Texto completo Resumen
106. Jackson Y. International migration: global issue, local impact: the example of two parasites [in French]. Rev Med Suisse. 2009 May 6;5(202):1022-5. Resumen
107. Gonzalez-Granado LI, Rojo-Conejo P, Ruiz-Contreras J, et al. Chagas disease travels to Europe. Lancet. 2009 Jun 13;373(9680):2025. Resumen
108. Manzardo C, Trevino B, Gomez i Prat J, et al. Communicable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues. Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):4-11. Resumen
109. Takeno M, Seto S, Kawahara F, et al. Chronic Chagas' heart disease in a Japanese-Brazilian traveler: a case report. Jpn Heart J. 1999 May;40(3):375-82.Texto completo Resumen
110. Sánchez-Montalvá A, Salinas C, Sullerio E, et al. Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America. PLoS Negl Trop Dis. 2021 Jul;15(7):e0009528.Texto completo Resumen
111. Centers for Disease Control and Prevention. CDC Yellow Book 2024: travelers health. Section 5: travel-associated infections & diseases - trypanosomiasis, American/Chagas disease. May 2023 [internet publication].Texto completo
112. Blanco SB, Segura EL, Cura EN, et al. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health. 2000 Apr;5(4):293-301.Texto completo Resumen
113. Bittencourt AL. Possible risk factors for vertical transmission of Chagas' disease. Rev Inst Med Trop Sao Paulo. 1992 Sep-Oct;34(5):403-8. Resumen
114. Brutus L, Schneider D, Postigo J, et al. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1159-60. Resumen
115. Gürtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis. 2003 Jan;9(1):29-32.Texto completo Resumen
116. Olivera Mar A, Guillen Ortega F, Cruz Vidal S, et al. Serological and parasitological screening of Trypanosoma cruzi infection in mothers and newborns living in two Chagasic areas of Mexico. Arch Med Res. 2006 Aug;37(6):774-7. Resumen
117. Salas NA, Cot M, Schneider D, et al. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop Med Int Health. 2007 Dec;12(12):1498-505.Texto completo Resumen
118. Di Pentima MC, Hwang LY, Skeeter CM, et al. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis. 1999 Jun;28(6):1281-5. Resumen
119. Maldonado E, Morales-Pison S, Urbina F, et al. Vaccine design against Chagas disease focused on the use of nucleic acids. Vaccines (Basel). 2022 Apr 12;10(4):587.Texto completo Resumen
120. World Health Organization. New road map for neglected tropical diseases 2021-2030. 2023 [internet publication].Texto completo
121. Mills RM. Chagas disease: epidemiology and barriers to treatment. Am J Med. 2020 Nov;133(11):1262-5. Resumen
122. Monroy MC, Penados D, Pineda J, et al. A multidisciplinary, collaborative, inter-agency and comprehensive approach for the control of Chagas disease as a public health problem in Guatemala. Acta Trop. 2022 Jan;225:106157.Texto completo Resumen
123. Pinazo MJ, Rojas-Cortez M, Saravia R, et al. Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: the Bolivian chagas network. PLoS Negl Trop Dis. 2022 Feb;16(2):e0010072.Texto completo Resumen
124. Dias JC. Elimination of Chagas disease transmission: perspectives. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:41-5.Texto completo Resumen
125. Guhl F, Pinto N, Aguilera G. Sylvatic triatominae: a new challenge in vector control transmission. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:71-5.Texto completo Resumen
126. Noireau F. Wild Triatoma infestans, a potential threat that needs to be monitored. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:60-4.Texto completo Resumen
127. Meymandi S, Hernandez S, Park S, et al. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018 Jun 26;10(3):373-88.Texto completo Resumen
128. Office for Health Improvement and Disparities. Guidance on Chagas disease: migrant health guide. Feb 2021 [internet publication].Texto completo
129. Milei J, Guerri-Guttenberg RA, Grana DR, et al. Prognostic impact of Chagas disease in the United States. Am Heart J. 2009 Jan;157(1):22-9. Resumen
130. Dias JP, Bastos C, Araujo E, et al. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop. 2008 May-Jun;41(3):296-300.Texto completo Resumen
131. Sosa-Estani S, Viotti R, Segura EL. Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:167-80.Texto completo Resumen
132. Gomes YM, Lorena VM, Luquetti AO. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:115-21.Texto completo Resumen
133. Dubner S, Schapachnik E, Riera AR, et al. Chagas disease: state-of-the-art of diagnosis and management. Cardiol J. 2008;15(6):493-504. Resumen
134. Brasil PE, De Castro L, Hasslocher-Moreno AM, et al. ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infect Dis. 2010 Nov 25;10:337.Texto completo Resumen
135. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007 Mar 6;115(9):1101-8.Texto completo Resumen
136. Benchimol Barbosa PR. Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease. Braz J Med Biol Res. 2007 Feb;40(2):167-78.Texto completo Resumen
137. Bestetti RB, Dalbo CM, Arruda CA, et al. Predictors of sudden cardiac death for patients with Chagas' disease: a hospital-derived cohort study. Cardiology. 1996 Nov-Dec;87(6):481-7. Resumen
138. Rojas LZ, Glisic M, Pletsch-Borba L, et al. Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Jun;12(6):e0006567.Texto completo Resumen
139. Ralston K, Zaidel E, Acquatella H, et al. WHF recommendations for the use of echocardiography in Chagas disease. Glob Heart. 2023;18(1):27.Texto completo Resumen
140. Pinazo MJ, Gascon J, Alonso-Padilla J. How effective are rapid diagnostic tests for Chagas disease? Expert Rev Anti Infect Ther. 2021 Dec;19(12):1489-94. Resumen
141. Suescún-Carrero SH, Tadger P, Sandoval Cuellar C, et al. Rapid diagnostic tests and ELISA for diagnosing chronic Chagas disease: systematic revision and meta-analysis. PLoS Negl Trop Dis. 2022 Oct;16(10):e0010860.Texto completo Resumen
142. Moreira OC, Fernandes AG, Gomes NLDS, et al. Validation of the NAT chagas IVD kit for the detection and quantification of Trypanosoma cruzi in blood samples of patients with Chagas disease. Life (Basel). 2023 May 24;13(6):1236.Texto completo Resumen
143. Kelly EA, Bulman CA, Gunderson EL, et al. Comparative performance of latest-generation and FDA-cleared serology tests for the diagnosis of Chagas disease. J Clin Microbiol. 2021 May 19;59(6):e00158-21.Texto completo Resumen
144. Otani MM, Vinelli E, Kirchhoff LV, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 2009 Jun;49(6):1076-82. Resumen
145. Caballero ZC, Sousa OE, Marques WP, et al. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol. 2007 Aug;14(8):1045-9.Texto completo Resumen
146. Meneghelli UG, Peria FM, Darezzo FM, et al. Clinical, radiographic, and manometric evolution of esophageal involvement by Chagas' disease. Dysphagia. 2005 Winter;20(1):40-5. Resumen
147. Meneghelli UG. Chagasic enteropathy. Rev Soc Bras Med Trop. 2004 May-Jun;37(3):252-60. Resumen
148. Benchimol-Barbosa PR. Predictors of mortality in Chagas' disease: the impact of atrial fibrillation and oral transmission on infected population. Int J Cardiol. 2009 Apr 3;133(2):275-7. Resumen
149. Dantas RO. Comparison between idiopathic achalasia and achalasia caused by Chagas' disease: a review on the publications about the subject [in Portuguese]. Arq Gastroenterol. 2003 Apr-Jun;40(2):126-30. Resumen
150. Dantas RO. Effect of successive swallows on oesophageal motility of normal volunteers, patients with Chagas' disease and patients with idiopathic achalasia. Neurogastroenterol Motil. 2003 Feb;15(1):57-62. Resumen
151. Dantas RO. Vigorous achalasia in Chagas' disease. Dis Esophagus. 2002;15(4):305-8. Resumen
152. Dantas RO. Upper esophageal sphincter pressure in patients with Chagas' disease and primary achalasia. Braz J Med Biol Res. 2000 May;33(5):545-51.Texto completo Resumen
153. Dantas RO. Dysphagia in patients with Chagas' disease. Dysphagia. 1998 Winter;13(1):53-7. Resumen
154. Xavier SS, Sousa AS, Hasslocher-Moreno A. Application of the new classification of cardiac insufficiency (ACC/AHA) in chronic Chagas cardiopathy: a critical analysis of the survival curves. SOCERJ. 2005;18:227-32.Texto completo
155. Carrasco HA, Barboza JS, Inglessis G, et al. Left ventricular cineangiography in Chagas' disease: detection of early myocardial damage. Am Heart J. 1982 Sep;104(3):595-602. Resumen
156. Kuschnir E, Sgammini H, Castro R, et al. Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy [in Spanish]. Arq Bras Cardiol. 1985 Oct;45(4):249-56. Resumen
157. Bern C, Montgomery SP, Katz L, et al. Chagas disease and the US blood supply. Curr Opin Infect Dis. 2008 Oct;21(5):476-82. Resumen
158. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in Transplant Working Group. Am J Transplant. 2011 Apr;11(4):672-80.Texto completo Resumen
159. Gross PA, Barrett TL, Dellinger EP, et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis. 1994 Mar;18(3):421. Resumen
160. Pan American Health Organization. Guide to the diagnosis and treatment of chagas disease. Jun 2019 [internet publication].Texto completo
161. Coura JR. Present situation and new strategies for Chagas disease chemotherapy - a proposal. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):549-54.Texto completo Resumen
162. Fernandes CD, Tiecher FM, Balbinot MM, et al. Efficacy of benznidazole treatment for asymptomatic Chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up. Mem Inst Oswaldo Cruz. 2009 Feb;104(1):27-32.Texto completo Resumen
163. Dias JC, Coura JR, Yasuda MA. The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease. Rev Soc Bras Med Trop. 2014 Jan-Feb;47(1):123-5.Texto completo Resumen
164. Norman FF, López-Vélez R. Chagas disease and breast-feeding. Emerg Infect Dis. 2013 Oct;19(10):1561-6.Texto completo Resumen
165. Abbott A, Montgomery SP, Chancey RJ. Characteristics and adverse events of patients for whom nifurtimox was released through CDC-sponsored investigational new drug program for treatment of Chagas disease - United States, 2001-2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11;71(10):371-4.Texto completo Resumen
166. World Health Organization. Chagas disease (American trypanosomiasis): treatment. 2018 [internet publication].Texto completo
167. Díaz-Bello Z, de Noya BA, Muñoz-Calderón A, et al. Ten-year follow-up of the largest oral chagas disease outbreak. Laboratory biomarkers of infection as indicators of therapeutic failure. Acta Trop. 2021 Oct;222:106034. Resumen
168. Centers for Disease Control and Prevention. Parasites - American trypanosomiasis (also known as Chagas disease): congenital chagas disease. Jun 2021 [internet publication].Texto completo
169. Bestetti RB, Theodoropoulos TA. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J Card Fail. 2009 Apr;15(3):249-55. Resumen
170. Urbina JA. Recent clinical trials for the etiological treatment of chronic Chagas disease: advances, challenges and perspectives. J Eukaryot Microbiol. 2015 Jan-Feb;62(1):149-56. Resumen
171. Campi-Azevedo AC, Gomes JA, Teixeira-Carvalho A, et al. Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events. Immunobiology. 2015 May;220(5):564-74. Resumen
172. Barbosa JL, Thiers CA, de Bragança Pereira B, et al. Impact of the use of benznidazole followed by antioxidant supplementation in the prevalence of ventricular arrhythmias in patients with chronic Chagas disease: pilot study. Am J Ther. 2016 Nov/Dec;23(6):e1474-83. Resumen
173. Fabbro DL, Danesi E, Olivera V, et al. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312.Texto completo Resumen
174. Hasslocher-Moreno AM, Saraiva RM, Sangenis LHC, et al. Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: a long-term follow up study. EClinicalMedicine. 2021 Jan;31:100694.Texto completo Resumen
175. Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic chagas' cardiomyopathy. N Engl J Med. 2015 Oct;373(14):1295-306.Texto completo Resumen
176. Vallejo M, Reyes PPA, Garcia MM, et al. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD004102.Texto completo Resumen
177. Bittencourt HS, Rodrigues Junior Ede S, Cruz CG, et al. Neuromuscular electrical stimulation in a patient with chronic heart failure due to Chagas disease: a case report. Clinics (Sao Paulo). 2011;66(5):927-8.Texto completo Resumen
178. Mendes MFA, Lopes WS, Nogueira GA, et al. Aerobic physical exercise in women with Chagas disease [in Portuguese]. Fisioter Mov. 2011;24(4):591-601.Texto completo
179. Lima MM, Rocha MO, Nunes MC, et al. A randomized trial of the effects of exercise training in Chagas cardiomyopathy. Eur J Heart Fail. 2010 Aug;12(8):866-73.Texto completo Resumen
180. Fialho PH, Tura BR, Sousa AS, et al. Effects of an exercise program on the functional capacity of patients with chronic Chagas' heart disease, evaluated by cardiopulmonary testing. Rev Soc Bras Med Trop. 2012 Mar-Apr;45(2):220-4. Resumen
181. Mediano MF, Mendes Fde S, Pinto VL, et al. Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study. Rev Soc Bras Med Trop. 2016 May-Jun;49(3):319-28.Texto completo Resumen
182. Martí-Carvajal AJ, Kwong JS. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy. Cochrane Database Syst Rev. 2016 Jul 8;(7):CD009077.Texto completo Resumen
183. Tanowitz HB, Machado FS, Jelicks LA, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis. 2009 May-Jun;51(6):524-39.Texto completo Resumen
184. Aulet F, Riarte A, Pattin M, et al. Chagas disease and kidney transplantation. Transplant Proc. 1991 Oct;23(5):2653. Resumen
185. de Arteaga J, Massari PU, Galli B, et al. Renal transplantation and Chagas' disease. Transplant Proc. 1992 Oct;24(5):1900-1. Resumen
186. de Faria JB, Alves G. Transmission of Chagas' disease through cadaveric renal transplantation. Transplantation. 1993 Dec;56(6):1583-4. Resumen
187. Vazquez MC, Riarte A, Pattin M, et al. Chagas' disease can be transmitted through kidney transplantation. Transplant Proc. 1993 Dec;25(6):3259-60. Resumen
188. Vazquez MC, Sabbatiello R, Schiavelli R, et al. Chagas disease and transplantation. Transplant Proc. 1996 Dec;28(6):3301-3. Resumen
189. Rassi A Jr, Dias JC, Marin-Neto JA, et al. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart. 2009 Apr;95(7):524-34. Resumen
190. Riarte A, Luna C, Sabatiello R, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999 Sep;29(3):561-7. Resumen
191. Altcheh J, Moscatelli G, Caruso M, et al. Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation. PLoS Negl Trop Dis. 2023 May;17(5):e0010850.Texto completo Resumen
192. Keenan M, Chaplin JH. A new era for Chagas disease drug discovery? Prog Med Chem. 2015;54:185-230. Resumen
193. Morilla MJ, Romero EL. Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis. Nanomedicine (Lond). 2015 Feb;10(3):465-81. Resumen
194. Menna-Barreto R. Chagas disease - from cellular and molecular aspects of Trypanosoma cruzi-host interactions to the clinical intervention. IntechOpen; 2022.Texto completo
195. Torrico F, Gascón J, Ortiz L, et al. A phase 2, randomized, multicenter, placebo-controlled, proof-of-concept trial of oral fexinidazole in adults with chronic indeterminate Chagas disease. Clin Infect Dis. 2023 Feb 8;76(3):e1186-94.Texto completo Resumen
196. Borges Migliavaca C, Stein C, Colpani V, et al. Isosorbide and nifedipine for Chagas' megaesophagus: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Sep;12(9):e0006836.Texto completo Resumen
197. Stein C, Migliavaca CB, Colpani V, et al. Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis. PLoS Negl Trop Dis. 2018 Aug;12(8):e0006742.Texto completo Resumen
198. NIH US National Library of Medicine: ClinicalTrials.gov. A trial testing amiodarone in Chagas cardiomiopathy (ATTACH). June 2017 [internet publication].Texto completo
199. Cortes-Serra N, Losada-Galvan I, Pinazo MJ, et al. State-of-the-art in host-derived biomarkers of Chagas disease prognosis and early evaluation of anti-Trypanosoma cruzi treatment response. Biochim Biophys Acta Mol Basis Dis. 2020 Jul 1;1866(7):165758.Texto completo Resumen
200. Campos de Carvalho AC, Goldenberg RC, Jelicks LA, et al. Cell therapy in Chagas disease. Interdiscip Perspect Infect Dis. 2009;2009:484358.Texto completo Resumen
201. Soares MB, dos Santos RR. Current status and perspectives of cell therapy in Chagas disease. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:325-32.Texto completo Resumen
202. Zhang Y, Mi JY, Rui YJ, et al. Stem cell therapy for the treatment of parasitic infections: is it far away? Parasitol Res. 2014 Feb;113(2):607-12. Resumen
203. de Carvalho KA, Abdelwahid E, Ferreira RJ, et al. Preclinical stem cell therapy in Chagas Disease: perspectives for future research. World J Transplant. 2013 Dec 24;3(4):119-26.Texto completo Resumen
204. Silva DN, de Freitas Souza BS, Azevedo CM, et al. Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy. Stem Cell Res Ther. 2014 Jul 1;5(4):81.Texto completo Resumen
205. Soares MB, Lima RS, Rocha LL, et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic Chagasic mice. Am J Pathol. 2004 Feb;164(2):441-7. Resumen
206. Goldenberg RC, Jelicks LA, Fortes FS, et al. Bone marrow cell therapy ameliorates and reverses Chagasic cardiomyopathy in a mouse model. J Infect Dis. 2008 Feb 15;197(4):544-7. Resumen
207. Vilas-Boas F, Feitosa GS, Soares MB, et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease [in Portuguese]. Arq Bras Cardiol. 2006 Aug;87(2):159-66. Resumen
208. Ribeiro Dos Santos R, Rassi S, Feitosa G, et al; Chagas Arm of the MiHeart Study Investigators. Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial. Circulation. 2012 May 22;125(20):2454-61.Texto completo Resumen
209. Camargo EP. Perspectives of vaccination in Chagas disease revisited. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:275-80.Texto completo Resumen
210. Cazorla SI, Frank FM, Malchiodi EL. Vaccination approaches against Trypanosoma cruzi infection. Expert Rev Vaccines. 2009 Jul;8(7):921-35. Resumen
211. Duschak VG, Couto AS. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem. 2009;16(24):3174-202. Resumen
212. Schnapp AR, Eickhoff CS, Sizemore D, et al. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun. 2002 Sep;70(9):5065-74.Texto completo Resumen
213. Bontempi IA, Vicco MH, Cabrera G, et al. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease. Vaccine. 2015 Mar 3;33(10):1274-83. Resumen
214. Serna C, Lara JA, Rodrigues SP, et al. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease. Vaccine. 2014 Jun 12;32(28):3525-32.Texto completo Resumen
215. Tekiel V, Alba-Soto CD, Gonzalez Cappa SM, et al. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009 Feb 25;27(9):1323-32. Resumen
216. Gupta S, Wan X, Zago MP, et al. Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease. PLoS Negl Trop Dis. 2013;7(1):e2018.Texto completo Resumen
217. Basso B. Modulation of immune response in experimental Chagas disease. World J Exp Med. 2013 Feb 20;3(1):1-10.Texto completo Resumen
218. Balouz V, Cámara Mde L, Cánepa GE, et al. Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi. Clin Vaccine Immunol. 2015 Mar;22(3):304-12. Resumen
219. Jannin J, Salvatella R, eds. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: OPS/HDM/CD/425-06; 2006:28.
220. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2197-223. Resumen
221. Lee BY, Bacon KM, Bottazzi ME, et al. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013 Apr;13(4):342-8.Texto completo Resumen
222. World Health Organization. World Health Report 2004: changing history. Geneva: WHO; 2004:120-1,126-7.Texto completo
223. Chadalawada S, Sillau S, Archuleta S, et al. Risk of chronic cardiomyopathy among patients with the acute phase or indeterminate form of Chagas disease: a systematic review and meta-analysis. JAMA Netw Open. 2020 Aug 3;3(8):e2015072.Texto completo Resumen
224. Saraiva RM, Mediano MFF, Mendes FS, et al. Chagas heart disease: an overview of diagnosis, manifestations, treatment, and care. World J Cardiol. 2021 Dec 26;13(12):654-75.Texto completo Resumen
225. Martins-Melo FR, Alencar CH, Ramos AN Jr, et al. Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007. PLoS Negl Trop Dis. 2012;6(2):e1508.Texto completo Resumen
226. Alvarez MG, Bertocchi GL, Cooley G, et al. Treatment success in Trypanosoma cruzi infection is predicted by early changes in serially monitored parasite-specific T and B cell responses. PLoS Negl Trop Dis. 2016 Apr;10(4):e0004657.Texto completo Resumen
227. Zeledón R, Dias JC, Brilla-Salazar A, et al. Does a spontaneous cure for Chagas' disease exist? Rev Soc Bras Med Trop. 1988 Jan-Mar;21(1):15-20.
228. Francolino SS, Antunes AF, Talice R, et al. New evidence of spontaneous cure in human Chagas' disease. Rev Soc Bras Med Trop. 2003 Jan-Feb;36(1):103-7.Texto completo Resumen
229. Dias JC, Dias E, Martins-Filho OA, et al. Further evidence of spontaneous cure in human Chagas disease. Rev Soc Bras Med Trop. 2008 Sep-Oct;41(5):505-6.Texto completo Resumen
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad